The Intricate Process of Calcification in Granuloma Formation and the Complications Following M. tuberculosis

Nickolas Yedgarian1, Jacqueline Agopian1, Brandon Flaig1

  • 1College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.

Biomolecules
|July 29, 2025
PubMed

Insights

Tuberculosis (TB) infection can lead to lung tissue damage through calcification and fibrosis. New experimental therapies show promise for treating these complications, offering hope beyond current antifibrotic drugs.

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Background:

  • Mycobacterium tuberculosis (TB) infection presents a significant global health challenge.
  • Immune responses to TB can paradoxically cause lung tissue damage via necrosis and calcification.
  • Calcification is a recognized consequence of chronic granuloma formation in tuberculosis.

Purpose of the Study:

  • To review recent literature on the pathogenesis of M. tuberculosis.
  • To explore mechanisms of calcification during granuloma formation.
  • To examine subsequent disease complications and potential therapeutic strategies.

Main Methods:

  • Literature review of recent studies.
  • Analysis of molecular pathways involved in fibrosis and calcification (e.g., IL-1β, TGF-β, TNF-α).
  • Evaluation of current and experimental therapeutic interventions.

Main Results:

  • Current antifibrotic drugs (nintedanib, pirfenidone) carry risks of latent TB reactivation.
  • Experimental therapies like artemisinin derivatives show preclinical promise for TB fibrosis.
  • Cell-based therapies (e.g., bone marrow-derived mononuclear cells) are being investigated for combined antifibrotic and immunomodulatory effects.

Conclusions:

  • Understanding TB pathogenesis and calcification mechanisms is crucial for managing lung damage.
  • Novel therapeutic approaches are needed to address TB-associated fibrosis and calcification effectively.
  • Further research into experimental therapies may offer safer and more effective treatments for TB complications.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
362
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
446
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
206
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
326
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
239
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
442